This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Standalone Sep 2026 quarter: revenue Rs 4,520.49 lakh vs Rs 4,690.24 lakh a year earlier
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 6.8 pts less than Nifty Microcap 250 and 5.9 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Standalone revenue for the Sep 2026 quarter was Rs 4,520.49 lakh, down 3.6% from Rs 4,690.24 lakh a year earlier; after-tax profit rose 12.4% to Rs 723.96 lakh from Rs 644.22 lakh. Operating margin before interest, tax, depreciation and amortisation rose from 18.4% to 21.3%. Standalone half-year: revenue Rs 9,088.31 lakh, after-tax profit Rs 1,532.38 lakh. Net operating cash flow for the half year was negative Rs 81 lakh. Prior figures regrouped.
Sales fell, but after-tax profit and operating margins improved. Negative operating cash flow is a concern, though borrowings are low versus equity.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹45.20 Cr | ₹46.90 Cr | −3.6% |
| Operating profit | ₹8.37 Cr | ₹7.36 Cr | +13.7% |
| Profit after tax | ₹7.24 Cr | ₹6.44 Cr | +12.4% |
| EBITDA margin | 21.3% | 18.4% | +2.9 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.